Patent 10899747 was granted and assigned to Athenex on January, 2021 by the United States Patent and Trademark Office.
The present application is directed to biaryl piperidine amide compounds, or pharmaceutically acceptable salts, solvates, and prodrugs thereof, and methods of use thereof.